Information  X 
Enter a valid email address

Synairgen swings to FY pretax profit

By BFN News | 09:21 AM | Tuesday 03 March, 2015


Synairgen has swung to a FY pretax profit of £1.13m, from a loss of £2.27m. Revenue was £4.3m, from nil. Chairman Simon Shaw said: "We are delighted with the progress Synairgen has made during what has been a transformational year with the licensing deal of our novel therapeutic, SNG001, for development and commercialisation by AstraZeneca. "We are engaged in due diligence on a number of novel development opportunities to which Synairgen's platform could add significant value in the near and medium term and we expect a number of these to enter our development pipeline during the coming period." At 9:21am: (LON:SNG) Synairgen PLC share price was +1p at 28.5p Story provided by StockMarketWire.com

a d v e r t i s e m e n t